Krishna Ella never expected to be holding the key to fighting a newglobal health emergency. Yet, his Indian firm, Bharat Biotech, has become the first in the world to have two vaccine candidates against therapidly spreading Zika virus, which has infected millions of people in Latin America and has the potential to spread worldwide.
Zika doesn’t cause much harm to adults. Most infected individuals are symptomless, and those who experience a bout of fever or red rash often recover within a few days. What has raised alarm is its link to theserious neurological birth defects known as microcephaly, in which babies are born with tiny brains… Read more : Quartz India, 04.02.2016